Todd Driver, | |
9 Corporate Park Ste 150, Irvine, CA 92606-5172 | |
(949) 653-9500 | |
(949) 653-9513 |
Full Name | Todd Driver |
---|---|
Gender | Male |
Speciality | Ophthalmology |
Experience | 10 Years |
Location | 9 Corporate Park Ste 150, Irvine, California |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1245650985 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207W00000X | Ophthalmology | A140821 (California) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Daniel C Kline Md Inc | 0143308346 | 5 |
News Archive
Today's early morning highlights from the major news organizations, including articles about House Republican plans to seek a delay in the health law's requirement that nearly all Americans get health insurance.
InspireMD, developers of the novel MGuard(TM) coronary MicroNet stent system, will introduce MGuard Prime at its booth #2052 at the TCT Conference in Washington DC, September 23-25, 2010. MGuard Prime presents an advanced Co-Cr Design of 80 micron struts along with InspireMD's unique MicroNet(R) Mesh Technology.
Timing is everything, it seems, even in science. A team led by Johns Hopkins scientists has unraveled the first step in translating genetic information in order to build a protein, only to find that it's not one step but two.
BeyondSpring Pharmaceuticals, Inc., a clinical stage biopharmaceutical company focused on the development of innovative cancer therapies, today announced that it has filed two new method of treatment patent applications with the United States Patent and Trademark Office to cover methods of treating brain tumors as well as cancers expressing a mutant form of RAS protein through administration of the Company's lead compound, Plinabulin.
Cardiovascular disease remains the leading cause of mortality in Europe, and World Health Organization (WHO) heart disease goals will not be achieved by 2025 unless urgent action is taken. That is the finding of a European Society of Cardiology (ESC) report published today.
› Verified 3 days ago
Entity Name | University Of California Sfgh Medical Group |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1366417420 PECOS PAC ID: 5496668410 Enrollment ID: O20031112000551 |
News Archive
Today's early morning highlights from the major news organizations, including articles about House Republican plans to seek a delay in the health law's requirement that nearly all Americans get health insurance.
InspireMD, developers of the novel MGuard(TM) coronary MicroNet stent system, will introduce MGuard Prime at its booth #2052 at the TCT Conference in Washington DC, September 23-25, 2010. MGuard Prime presents an advanced Co-Cr Design of 80 micron struts along with InspireMD's unique MicroNet(R) Mesh Technology.
Timing is everything, it seems, even in science. A team led by Johns Hopkins scientists has unraveled the first step in translating genetic information in order to build a protein, only to find that it's not one step but two.
BeyondSpring Pharmaceuticals, Inc., a clinical stage biopharmaceutical company focused on the development of innovative cancer therapies, today announced that it has filed two new method of treatment patent applications with the United States Patent and Trademark Office to cover methods of treating brain tumors as well as cancers expressing a mutant form of RAS protein through administration of the Company's lead compound, Plinabulin.
Cardiovascular disease remains the leading cause of mortality in Europe, and World Health Organization (WHO) heart disease goals will not be achieved by 2025 unless urgent action is taken. That is the finding of a European Society of Cardiology (ESC) report published today.
› Verified 3 days ago
Entity Name | Daniel C Kline Md Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1518145465 PECOS PAC ID: 0143308346 Enrollment ID: O20080428000552 |
News Archive
Today's early morning highlights from the major news organizations, including articles about House Republican plans to seek a delay in the health law's requirement that nearly all Americans get health insurance.
InspireMD, developers of the novel MGuard(TM) coronary MicroNet stent system, will introduce MGuard Prime at its booth #2052 at the TCT Conference in Washington DC, September 23-25, 2010. MGuard Prime presents an advanced Co-Cr Design of 80 micron struts along with InspireMD's unique MicroNet(R) Mesh Technology.
Timing is everything, it seems, even in science. A team led by Johns Hopkins scientists has unraveled the first step in translating genetic information in order to build a protein, only to find that it's not one step but two.
BeyondSpring Pharmaceuticals, Inc., a clinical stage biopharmaceutical company focused on the development of innovative cancer therapies, today announced that it has filed two new method of treatment patent applications with the United States Patent and Trademark Office to cover methods of treating brain tumors as well as cancers expressing a mutant form of RAS protein through administration of the Company's lead compound, Plinabulin.
Cardiovascular disease remains the leading cause of mortality in Europe, and World Health Organization (WHO) heart disease goals will not be achieved by 2025 unless urgent action is taken. That is the finding of a European Society of Cardiology (ESC) report published today.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Todd Driver, 9 Corporate Park Ste 150, Irvine, CA 92606-5172 Ph: (949) 653-9500 | Todd Driver, 9 Corporate Park Ste 150, Irvine, CA 92606-5172 Ph: (949) 653-9500 |
News Archive
Today's early morning highlights from the major news organizations, including articles about House Republican plans to seek a delay in the health law's requirement that nearly all Americans get health insurance.
InspireMD, developers of the novel MGuard(TM) coronary MicroNet stent system, will introduce MGuard Prime at its booth #2052 at the TCT Conference in Washington DC, September 23-25, 2010. MGuard Prime presents an advanced Co-Cr Design of 80 micron struts along with InspireMD's unique MicroNet(R) Mesh Technology.
Timing is everything, it seems, even in science. A team led by Johns Hopkins scientists has unraveled the first step in translating genetic information in order to build a protein, only to find that it's not one step but two.
BeyondSpring Pharmaceuticals, Inc., a clinical stage biopharmaceutical company focused on the development of innovative cancer therapies, today announced that it has filed two new method of treatment patent applications with the United States Patent and Trademark Office to cover methods of treating brain tumors as well as cancers expressing a mutant form of RAS protein through administration of the Company's lead compound, Plinabulin.
Cardiovascular disease remains the leading cause of mortality in Europe, and World Health Organization (WHO) heart disease goals will not be achieved by 2025 unless urgent action is taken. That is the finding of a European Society of Cardiology (ESC) report published today.
› Verified 3 days ago
Dr. Stephen B Prepas, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 850 Health Sciences Rd, Irvine, CA 92617 Phone: 949-824-2020 | |
Dr. Alexandra Christine Chebil, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 2192 Martin, Suite 135, Irvine, CA 92612 Phone: 949-251-0229 Fax: 949-251-8945 | |
Dr. Olivia L Lee, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 850 Health Sciences Rd, Irvine, CA 92617 Phone: 949-824-2020 | |
Dr. Mohammad Riazi Esfahani, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 850 Health Sciences Rd, Irvine, CA 92617 Phone: 949-824-6109 Fax: 949-824-2073 | |
Dr. Eran Duzman, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 4605 Barranca Parkway, Suite# 100, Irvine, CA 92604 Phone: 949-733-2002 Fax: 949-733-1854 | |
Dr. Vivek R Patel, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 850 Health Sciences Rd, Irvine, CA 92617 Phone: 949-824-2020 | |
Ken Lin, M.D., PH.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 850 Health Sciences Rd, Irvine, CA 92617 Phone: 949-824-2020 |